Olpadronate (Gador)

N/A

Report date: 2025/08/15 14:29:27
NME

Base Information

Drug NameOlpadronate (Gador)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitorsVitamin D receptor agonists
TargetsVitamin D receptorHMG-CoA reductase
Therapy Area/IndicationsHypercalcemiaOsteitis DeformansOsteoporosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGador Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacific PharmaceuticalsGador Sa
Active IndicationsN/A
Inactive IndicationsHypercalcemiaOsteitis DeformansOsteoporosis +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia